Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention
NCT ID: NCT02886143
Last Updated: 2016-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
274 participants
INTERVENTIONAL
2015-10-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
NCT05820139
Indwelling Urinary Catheterization Versus Clean Intermittent Catheterization for the Short-term Management of Hospitalized Patients With Transient Acute Urinary Retention
NCT02942641
Accuracy of Bladder Scanners in Post-operative Voiding Trials
NCT03028753
Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery
NCT03048682
Timing of Active Void Trials After Urogynecologic Procedures
NCT05885958
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Voiding Trial (instillation of sterile saline)
Patients randomized to receive an active voiding trial will have the bladder filled with 250-400 cc of sterile saline (or until the bladder was full) via the lumen of the urinary catheter before the urinary catheter is removed. The patient will then be immediately assisted to void. Physician teams will follow a standardized algorithm for the management of urinary retention arising during the study.
Active Voiding Trial
Nursing protocol:
1. Instill 250-400 cc of STERILE SALINE via the lumen of the Foley catheter into the bladder via gravity drainage or slow push
2. Clamp the Foley
3. Deflate the catheter balloon and remove the catheter from the bladder.
4. Record the amount of saline that was instilled into the bladder.
5. Immediately assist the patient to void. Report the amount instilled and the amount voided to the physician within one hour a. Unless the patient reports extreme bladder fullness or pain, give the patient one hour to urinate
7\. If the patient fails the voiding trial, the physician will decide to do in and out catheterization or place a new Foley catheter
Passive Voiding Trial
For patients randomized to receive a passive voiding trial, the urinary catheter will be removed, the bladder will fill with urine naturally, and the patient will be assisted to void when he or she reports the urge. To ensure uniformity in the intervention, all voiding trials in the study will be supervised by an experienced nurse who will ensure that the protocol is followed.
Passive Voiding Trial
Nursing protocol:
1. Deflate the catheter balloon and remove the catheter from the bladder.
2. Record the time that the catheter was removed and the time the patient is due to void (approximately 6 hours).
3. 5\. If the patient has not voided within 5 hours, assist the patient to try to void.
6\. If the patient is unable to void, is only voiding in small amounts, or reports fullness or abdominal pain, perform a bladder scan.
7\. If the patient has not voided after 6 hours, report this to the physician along with the results of the bladder scan 8. The physician will decide to do in and out catheterization or place a new Foley catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Voiding Trial
Nursing protocol:
1. Instill 250-400 cc of STERILE SALINE via the lumen of the Foley catheter into the bladder via gravity drainage or slow push
2. Clamp the Foley
3. Deflate the catheter balloon and remove the catheter from the bladder.
4. Record the amount of saline that was instilled into the bladder.
5. Immediately assist the patient to void. Report the amount instilled and the amount voided to the physician within one hour a. Unless the patient reports extreme bladder fullness or pain, give the patient one hour to urinate
7\. If the patient fails the voiding trial, the physician will decide to do in and out catheterization or place a new Foley catheter
Passive Voiding Trial
Nursing protocol:
1. Deflate the catheter balloon and remove the catheter from the bladder.
2. Record the time that the catheter was removed and the time the patient is due to void (approximately 6 hours).
3. 5\. If the patient has not voided within 5 hours, assist the patient to try to void.
6\. If the patient is unable to void, is only voiding in small amounts, or reports fullness or abdominal pain, perform a bladder scan.
7\. If the patient has not voided after 6 hours, report this to the physician along with the results of the bladder scan 8. The physician will decide to do in and out catheterization or place a new Foley catheter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has a Foley urethral catheter in place
* The physician has ordered the Foley urethral catheter to be discontinued
* 18 years of age and older
Exclusion Criteria
* Prisoners
* Women who are pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Virginia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tracey Krupski, MD
Vice Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracey L Krupski, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Virginia
References
Explore related publications, articles, or registry entries linked to this study.
Mills JT, Rapp DE, Shaw NM, Hougen HY, Agard HE, Case RM Jr, McMurry TL, Schenkman NS, Krupski TL. Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial. World J Urol. 2020 Sep;38(9):2247-2252. doi: 10.1007/s00345-019-03005-0. Epub 2019 Nov 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.